Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.58 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.50 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2736634 | 1.00 | TAAR1 (0.58) | TAAR1AOC3TRPA1RIPK1KDM4E | |
| SCHEMBL8159872 | 1.00 | TAAR1 (0.58) | TAAR1AOC3TRPA1RIPK1KDM4E | |
| SCHEMBL27548676 | 0.87 | TAAR1 (0.47) | TAAR1AOC3TRPA1RIPK1KDM4E | |
| SCHEMBL11755433 | 0.86 | GRIA4 (0.50) | TAAR1AOC3ALDH1A1 | |
| SCHEMBL11024335 | 0.86 | ESR1 (0.41) | TAAR1AOC3TRPA1RIPK1 | |
| SCHEMBL29224030 | 0.83 | TRPA1 (0.67) | TAAR1AOC3TRPA1RIPK1KDM4E | |
| SCHEMBL11024645 | 0.82 | HDAC4 (0.41) | TAAR1AOC3TRPA1RIPK1KDM4E | |
| SCHEMBL1553853 | 0.80 | RIPK1 (0.57) | TAAR1AOC3TRPA1RIPK1 | |
| SCHEMBL6280516 | 0.78 | RIPK1 (0.67) | TAAR1AOC3TRPA1RIPK1 | |
| SCHEMBL3672929 | 0.78 | TRPA1 (0.67) | TAAR1AOC3TRPA1RIPK1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117598319-A | Mite-killing composition containing fluazinam and bifenazate | 江西田友生化有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-104513326-B | Reversible addition-fragmentation chain transfer reagent and preparation and application thereof | PETROCHINA COMPANY LIMITED (CN) | 2016-05-11 | — | — | CN | claimed |
| CN-104513326-A | Reversible addition-fragmentation chain transfer reagent and preparation and application thereof | PETROCHINA CO LTD | 2015-04-15 | — | — | CN | claimed |
| JP-7278031-A | — | — | None | — | — | JP | disclosed |
| EP-3214099-B1 | METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | ZEON CORP (JP) | 2024-12-11 | — | — | EP | disclosed |
| CN-118048666-A | Methylsulfonate type pure tin electroplating solution additive and electroplating solution containing same | 成都开华化工研究所 | 2024-05-17 | — | — | CN | disclosed |
| CN-111406078-B | Catalyst for preparing polyethylene with broad bimodal molecular weight distribution | 埃克森美孚化学专利公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-114956933-A | Marker containing isotope oxygen atom and preparation method and application thereof | 清华大学 | 2022-08-30 | — | — | CN | disclosed |
| US-11407772-B2 | Optically-active cyclopentenone derivatives | TOHOKU UNIVERSITY (JP) | 2022-08-09 | — | — | US | disclosed |
| US-11364220-B2 | Compounds and methods for inhibiting CPY26 enzymes | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2022-06-21 | — | — | US | disclosed |
| CN-111517902-B | Aerobic oxidation system containing sulfinic acid, sulfonic acid or derivatives thereof and photo-oxidation promoting method thereof | 清华大学 | 2022-06-14 | — | — | CN | disclosed |
| US-4028438-A | INSECTICIDES, FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-06-07 | — | — | US | disclosed |
| US-3962307-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3944595-A | PROSTAGLANDIN | THE UPJOHN COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
| US-3933900-A | ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933899-A | ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933898-A | ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933897-A | ANTIULCER, ASTHMA, RENAL DYSFUNCTION | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933895-A | PROSTAGLANDINS, ANTIULCER, ANTICOAGULANTS, NASAL PATENCY, LABOR INDUCERS, WOUND HEALING | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3933896-A | ANTICOAGULANTS, ASTHMA, LABOR INDUCERS, CERVICAL DILATION | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11364220-B2 | Compounds and methods for inhibiting CPY26 enzymes | CYP2A6, CYP27A1, CYP26B1 | TAAR1 4541/4885AOC3 1322/4885TRPA1 4876/4885 |
| US-11407772-B2 | Optically-active cyclopentenone derivatives | PTGIS, PTGES, PTGES2 | TAAR1 4061/4885AOC3 1650/4885TRPA1 1484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.